Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
EMBO Reports is Scopus-indexed (Q1, CiteScore 9.5), WoS SCIE, DOAJ. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 1469-221XVerify ISSN ↗1469-3178Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 39 / 357 | 89th | Q1 |
| Biochemistry | 59 / 448 | 86th | Q1 |
| Molecular Biology | 73 / 414 | 82nd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q1, CiteScore 9.5.
EMBO Reports is Q1 in Genetics (rank 39 of 357), Q1 in Biochemistry (rank 59 of 448) and Q1 in Molecular Biology (rank 73 of 414), by CiteScore 2025.
EMBO Reports is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.5, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.711, quartile Q1, with an H-index of 227.
The publisher lists an article processing charge of about US$7,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
EMBO Reports is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 1469-221X and its online ISSN is 1469-3178.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
EMBO Reports has an h-index of 255 and a 2-year mean of 5.43 citations per paper (OpenAlex). Its Scopus CiteScore is 9.5, quartile Q1. On 2-year citations it ranks #48 of 353 Scopus journals in Genetics.
EMBO Reports published 330 papers in 2025; its busiest recent year was 2021 with 350. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (22.2%), China (15.2%) and Germany (7.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 13 retracted papers are recorded (1.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.